Cite
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.
MLA
Buckstein, Rena, et al. “The Burden of Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes and Ring Sideroblasts: An Analysis of the Prospective MDS-CAN Registry.” Leukemia & Lymphoma, vol. 64, no. 3, Mar. 2023, pp. 651–61. EBSCOhost, https://doi.org/10.1080/10428194.2022.2156793.
APA
Buckstein, R., Chodirker, L., Yee, K. W. L., Geddes, M., Leitch, H. A., Christou, G., Banerji, V., Leber, B., Khalaf, D., St-Hilaire, E., Finn, N., Nevill, T., Keating, M.-M., Storring, J., Parmentier, A., Thambipillai, A., Tang, D., Westcott, C., Cameron, C., & Spin, P. (2023). The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry. Leukemia & Lymphoma, 64(3), 651–661. https://doi.org/10.1080/10428194.2022.2156793
Chicago
Buckstein, Rena, Lisa Chodirker, Karen W L Yee, Michelle Geddes, Heather A Leitch, Grace Christou, Versha Banerji, et al. 2023. “The Burden of Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes and Ring Sideroblasts: An Analysis of the Prospective MDS-CAN Registry.” Leukemia & Lymphoma 64 (3): 651–61. doi:10.1080/10428194.2022.2156793.